Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study

Abstract We aimed to explore factors associated with prognosis in patients with metastatic small bowel adenocarcinoma (SBA) as well as to develop and validate nomograms to predict overall survival (OS) and cancer-specific survival (CSS). Relevant information of patients diagnosed between 2004 and 20...

Full description

Bibliographic Details
Main Authors: Hanlong Zhu, Si Zhao, Tianming Zhao, Kang Jiang, Lin Miao, Mingzuo Jiang, Fangyu Wang
Format: Article
Language:English
Published: Nature Portfolio 2022-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-09986-0
_version_ 1831840054726623232
author Hanlong Zhu
Si Zhao
Tianming Zhao
Kang Jiang
Lin Miao
Mingzuo Jiang
Fangyu Wang
author_facet Hanlong Zhu
Si Zhao
Tianming Zhao
Kang Jiang
Lin Miao
Mingzuo Jiang
Fangyu Wang
author_sort Hanlong Zhu
collection DOAJ
description Abstract We aimed to explore factors associated with prognosis in patients with metastatic small bowel adenocarcinoma (SBA) as well as to develop and validate nomograms to predict overall survival (OS) and cancer-specific survival (CSS). Relevant information of patients diagnosed between 2004 and 2016 was extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Nomograms for predicting 1- and 3-year OS and CSS were established with potential risk factors screened from multivariate cox regression analysis. The discrimination and accuracy of the nomograms were assessed by concordance index (C-index), calibration plots, and the area under receiver operating characteristic curve (AUC). In total, 373 SBA patients with M1 category were enrolled. Multivariate analysis revealed that age, size and grade of primary tumor, primary tumor surgery, and chemotherapy were significant variables associated with OS and CSS. The C-index values of the nomogram for OS were 0.715 and 0.687 in the training and validation cohorts, respectively. For CSS, it was 0.711 and 0.690, respectively. Through AUC, decision curve analysis (DCA) and calibration plots, the nomograms displayed satisfactory prognostic predicted ability and clinical application both in the OS and CSS. Our models could be served as a reliable tool for prognostic evaluation of patients with metastatic SBA, which are favorable in facilitating individualized survival predictions and clinical decision-making.
first_indexed 2024-12-23T06:04:15Z
format Article
id doaj.art-9c334f9ae52d46448e60f8822bbe2e18
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-23T06:04:15Z
publishDate 2022-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-9c334f9ae52d46448e60f8822bbe2e182022-12-21T17:57:36ZengNature PortfolioScientific Reports2045-23222022-04-0112111410.1038/s41598-022-09986-0Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort studyHanlong Zhu0Si Zhao1Tianming Zhao2Kang Jiang3Lin Miao4Mingzuo Jiang5Fangyu Wang6Department of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing UniversityDepartment of Gastroenterology, Affiliated Drum Tower Hospital, Medical School of Nanjing UniversityDepartment of Gastroenterology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Science and Peking Union Medical CollegeDepartment of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing UniversityMedical Centre for Digestive Diseases, Second Affiliated Hospital, Nanjing Medical UniversityDepartment of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing UniversityDepartment of Gastroenterology and Hepatology, Affiliated Jinling Hospital, Medical School of Nanjing UniversityAbstract We aimed to explore factors associated with prognosis in patients with metastatic small bowel adenocarcinoma (SBA) as well as to develop and validate nomograms to predict overall survival (OS) and cancer-specific survival (CSS). Relevant information of patients diagnosed between 2004 and 2016 was extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Nomograms for predicting 1- and 3-year OS and CSS were established with potential risk factors screened from multivariate cox regression analysis. The discrimination and accuracy of the nomograms were assessed by concordance index (C-index), calibration plots, and the area under receiver operating characteristic curve (AUC). In total, 373 SBA patients with M1 category were enrolled. Multivariate analysis revealed that age, size and grade of primary tumor, primary tumor surgery, and chemotherapy were significant variables associated with OS and CSS. The C-index values of the nomogram for OS were 0.715 and 0.687 in the training and validation cohorts, respectively. For CSS, it was 0.711 and 0.690, respectively. Through AUC, decision curve analysis (DCA) and calibration plots, the nomograms displayed satisfactory prognostic predicted ability and clinical application both in the OS and CSS. Our models could be served as a reliable tool for prognostic evaluation of patients with metastatic SBA, which are favorable in facilitating individualized survival predictions and clinical decision-making.https://doi.org/10.1038/s41598-022-09986-0
spellingShingle Hanlong Zhu
Si Zhao
Tianming Zhao
Kang Jiang
Lin Miao
Mingzuo Jiang
Fangyu Wang
Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study
Scientific Reports
title Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study
title_full Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study
title_fullStr Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study
title_full_unstemmed Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study
title_short Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study
title_sort development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma a retrospective cohort study
url https://doi.org/10.1038/s41598-022-09986-0
work_keys_str_mv AT hanlongzhu developmentandvalidationofprognosticnomogramsforpatientswithmetastaticsmallboweladenocarcinomaaretrospectivecohortstudy
AT sizhao developmentandvalidationofprognosticnomogramsforpatientswithmetastaticsmallboweladenocarcinomaaretrospectivecohortstudy
AT tianmingzhao developmentandvalidationofprognosticnomogramsforpatientswithmetastaticsmallboweladenocarcinomaaretrospectivecohortstudy
AT kangjiang developmentandvalidationofprognosticnomogramsforpatientswithmetastaticsmallboweladenocarcinomaaretrospectivecohortstudy
AT linmiao developmentandvalidationofprognosticnomogramsforpatientswithmetastaticsmallboweladenocarcinomaaretrospectivecohortstudy
AT mingzuojiang developmentandvalidationofprognosticnomogramsforpatientswithmetastaticsmallboweladenocarcinomaaretrospectivecohortstudy
AT fangyuwang developmentandvalidationofprognosticnomogramsforpatientswithmetastaticsmallboweladenocarcinomaaretrospectivecohortstudy